Home›People›Stephanie Bryant
Stephanie Bryant

Stephanie Bryant

Chief Scientific Officer and director at Renovare Therapeutics.

Director
Updated Nov 9, 2026·Latest SEC filing Oct 2, 2026·Suggest an edit

About Stephanie Bryant

Stephanie Bryant is a chief scientific officer and director at Renovare Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Stephanie Bryant in the role, so the role may have started earlier or lasted longer.

Renovare Therapeutics, Inc.
Chief Scientific Officer and director
2026 · Boulder, CO
Develops regenerative treatments for people with osteoarthritis.

Key Colleagues at Startups

The people Stephanie Bryant works with at each company, as listed on that company's latest Form D.

Renovare Therapeutics, Inc. · Form D, Oct 2, 2026
Elizabeth Scott
Elizabeth Scott
Chief Executive Officer and director
Karin Payne
Karin Payne
Chief Development Officer

Sources

  1. SECRenovare Therapeutics, Inc. Form D, filed Oct 2, 2026